Recap of MOASC Oncology Summit on March 11, 2017

The MOASC Oncology Summit was held on Saturday, March 11, 2017, at the Hyatt Regency in Huntington Beach. In case you missed it, below is a synopsis of the event.
Opening Remarks and Program Moderator: Lawrence D. Piro, M.D., Vice President, MOASC; President and CEO, The Angeles Clinic and Research Institute.
NON-SMALL CELL LUNG CANCER
Session Moderator: Ashkan Lashkari, M.D. MOASC Board of Directors, Wellness Oncology Hematology.
· Edward B. Garon M.D., MS Associate Professor; Director of Thoracic Oncology- David Geffen School of Medicine at UCLA, presented: Personalizing lung cancer therapy in the era of next generation sequencing, targeted therapies, and emerging immunotherapies.
· Karen L. Reckamp, M.D., MS Associate Professor, City of Hope Comprehensive Cancer Center, presented: The role of utilizing next generation sequencing diagnostics in the treatment of lung cancer.

HOW DIAGNOSTIC TESTING FITS IN
Session Moderator: Ashkan Lashkari, M.D., MOASC Board of Directors, Wellness Oncology Hematology.
· David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences, presented: Profiling with Caris Molecular Intelligence and R&D offering ADAPT Bio-targeting System.
· James Suh, MD, Senior Pathologist and Associate Medical Director Laboratory Director, Research Triangle Park, NC, Foundation Medicine, presented: Comprehensive Genomic Profiling: Key Insights for Patient Care

SPECIALTY PHARMACY SERVICES

· Presented by: George Missailidis, Regional Director, Specialty Sales, Walgreens, Co.

MACRA- The Final Rule and What You Need to know!
Sybil Green, JD, Director of Coverage and Reimbursement, ASCO.
PROSTATE CANCER
· Session Moderator: Kevin Chang, M.D., PhD, MOASC Board of Directors, Ventura County Hematology Oncology specialist.
· Przemyslaw Twardowski, M.D., Associate Professor Medical Oncology, City of Hope.
· David I. Quinn, M.D., Associate Professor Medical Oncology, USC

MULTIPLE MYELOMA
Session Moderator: Warren H. Fong, M.D. President, Medical Oncology Association of Southern California, Inc.
· Amrita Y. Krishnan, M.D., FACP Director, Judy and Bernard Briskin Center for Multiple Myeloma Research Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, presented: Autologous Stem Cell Transplantation for Myeloma in Era of New Drugs.

The entire program was recorded and you can view here: Oncology Summit.



No comments have been posted yet.